1. Home
  2. KALV vs NFGC Comparison

KALV vs NFGC Comparison

Compare KALV & NFGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$16.32

Market Cap

551.2M

Sector

Health Care

ML Signal

HOLD

Logo New Found Gold Corp

NFGC

New Found Gold Corp

HOLD

Current Price

$2.84

Market Cap

588.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALV
NFGC
Founded
N/A
2016
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
551.2M
588.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KALV
NFGC
Price
$16.32
$2.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
1
Target Price
$26.43
$5.00
AVG Volume (30 Days)
1.8M
1.7M
Earning Date
11-10-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,426,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$204.16
$1,903.79
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.30
$0.93
52 Week High
$17.28
$3.28

Technical Indicators

Market Signals
Indicator
KALV
NFGC
Relative Strength Index (RSI) 67.20 63.83
Support Level $13.28 $2.72
Resistance Level $16.80 $3.28
Average True Range (ATR) 1.09 0.18
MACD 0.28 0.06
Stochastic Oscillator 79.32 65.46

Price Performance

Historical Comparison
KALV
NFGC

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

About NFGC New Found Gold Corp

New Found Gold Corp is a mineral exploration company engaged in the acquisition, exploration and evaluation of resource properties with a focus on gold properties located in the Provinces of Newfoundland and Labrador and Ontario, Canada. The Company's exploration is focused on discovering and delineating gold resources. The Company has one material property: the Queensway Project located in Newfoundland, Canada (the Queensway Project).

Share on Social Networks: